TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,478,207 | -37.1% | 83,092 | -46.2% | 0.01% | -46.7% |
| Q1 2024 | $2,349,884 | +228.9% | 154,496 | +269.3% | 0.02% | +150.0% |
| Q4 2023 | $714,542 | -9.7% | 41,835 | -55.8% | 0.01% | -25.0% |
| Q3 2023 | $791,358 | +198.6% | 94,660 | +111.1% | 0.01% | +33.3% |
| Q3 2022 | $265,000 | -47.9% | 44,841 | +193.1% | 0.01% | -25.0% |
| Q3 2021 | $509,000 | -33.8% | 15,300 | -22.8% | 0.01% | -46.7% |
| Q2 2021 | $769,000 | -7.5% | 19,824 | +24.0% | 0.02% | -34.8% |
| Q4 2020 | $831,000 | +422.6% | 15,983 | -1.1% | 0.02% | +64.3% |
| Q1 2020 | $159,000 | -42.2% | 16,160 | -52.7% | 0.01% | +27.3% |
| Q1 2019 | $275,000 | +30.3% | 34,196 | +91.6% | 0.01% | +120.0% |
| Q3 2017 | $211,000 | +47.6% | 17,848 | -24.1% | 0.01% | +66.7% |
| Q2 2016 | $143,000 | – | 23,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
| Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
| RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
| Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
| Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
| ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
| Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
| ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
| Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |